Please address all five forces and please state your conclusion on whether the industry is attractive or not explicitly. (20 points, ~ 500 words) 2. Is the market segment of patients with sepsis associated – acute kidney injury (SA-AKI) a good market opportunity to target? Provide evidence to support your position. (10 points, ~ 100 words) 3. Discuss the pros and cons of the decision to switch from bovine AP to recAP. (10 points, ~ 100 words, bullet points are acceptable) 4. AM-Pharma needed to convince stakeholders to either invest in the company, support the AM-Pharma program or even buy the company. Please list at least six key success factors that you would make to stakeholders to support the company. (20 points, ~ 200 words, bullet points are acceptable) 5. Did AM-Pharma create value between 2001 and 2014? What were the four most important strategic decisions that were made during this time and what were the positive and negative consequences for each of those four strategic decisions? (25 points, ~ 650 words) 6. By mid-2014, the company was at a crossroads. Put yourself in the CEOs shoes. What strategic options should the company embark on? What are the pros and cons of each option? What options would you choose and why? Note: You are allowed to be more creative here in terms of thinking about options in areas that have not been explicitly mentioned in the closing paragraphs in the case. (15 points, ~ 650 words)
Use the order calculator below and get started! Contact our live support team for any assistance or inquiry.
[order_calculator]